US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 10.535
  • +0.065+0.62%
Trading Apr 18 15:50 ET
1.67BMarket Cap-7094P/E (TTM)

Neumora Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-42.11%-163.28M
-69.41%-51.44M
-85.43%-47.77M
-52.34%-114.9M
-3.45%-30.37M
-49.30%-25.76M
-95.92%-26.58M
-111.14%-32.19M
-181.84%-75.42M
-77.76%-29.35M
Net income from continuing operations
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
-78.54%-30.37M
-181.25%-43.04M
-139.05%-237.31M
-34.86%-26.97M
Operating gains losses
----
----
----
-988.68%-577K
---316K
---16K
32.32%-134K
5.93%-111K
59.23%-53K
----
Depreciation and amortization
12.46%668K
12.93%166K
18.49%173K
10.41%594K
12.21%147K
-2.67%146K
23.20%154K
11.36%147K
412.38%538K
107.94%131K
Other non cash items
338.98%67.38M
8,017.15%64.86M
-16.44%859K
-90.29%15.35M
-0.50%799K
-99.34%1.03M
11.44%302K
8,162.50%13.22M
123.38%158.09M
-82.72%803K
Change In working capital
-28.08%-8.9M
-153.27%-13.11M
-314.95%-1.19M
-623.00%-6.95M
-15.56%-5.18M
-75.38%555K
-20.97%1.73M
-338.96%-4.06M
69.24%-961K
-97.44%-4.48M
-Change in prepaid assets
-214.25%-11.4M
-293.18%-8.13M
-642.46%-6.89M
-60.53%-3.63M
8.98%-2.07M
-37.08%-928K
-24.02%136K
-251.08%-769K
-448.54%-2.26M
-2,451.69%-2.27M
-Change in payables and accrued expense
305.96%5.91M
-203.85%-4.07M
207.69%6.57M
-149.41%-2.87M
133.39%3.92M
-32.43%2.13M
-21.11%1.79M
-718.64%-10.72M
355.64%5.8M
186.33%1.68M
-Change in other current assets
--0
--0
--0
137.48%1.37M
-72.46%-6.25M
-1,080.00%-49K
--0
51,046.67%7.67M
-3,004.24%-3.66M
-10,758.82%-3.62M
-Change in other current liabilities
-86.36%-3.4M
-16.90%-913K
-44.35%-869K
-117.12%-1.83M
-194.72%-781K
-159.48%-602K
2.44%-200K
-74.82%-243K
-159.57%-841K
1.12%-265K
Cash from discontinued investing activities
Operating cash flow
-42.11%-163.28M
-69.41%-51.44M
-85.43%-47.77M
-52.34%-114.9M
-3.45%-30.37M
-49.30%-25.76M
-95.92%-26.58M
-111.14%-32.19M
-181.84%-75.42M
-77.76%-29.35M
Investing cash flow
Cash flow from continuing investing activities
138.32%64.39M
270.32%13.68M
42.66%23.82M
-20,464.63%-168.01M
-4,171.28%-8.03M
3,151.74%16.69M
-83,450.46%-91.07M
-317,159.26%-85.61M
92.73%-817K
39.35%-188K
Net PPE purchase and sale
77.10%-117K
-91.30%-44K
71.54%-37K
37.45%-511K
87.77%-23K
76.23%-130K
-66.97%-182K
-751.85%-176K
37.15%-817K
85.54%-188K
Net investment purchase and sale
144.72%69.09M
328.69%18.31M
41.78%23.85M
---154.5M
---8.01M
--16.82M
---90.89M
---72.43M
--0
----
Net other investing changes
64.69%-4.59M
----
----
---13M
--0
--0
--0
---13M
----
----
Cash from discontinued investing activities
Investing cash flow
138.32%64.39M
270.32%13.68M
42.66%23.82M
-20,464.63%-168.01M
-4,171.28%-8.03M
3,151.74%16.69M
-83,450.46%-91.07M
-317,159.26%-85.61M
92.73%-817K
39.35%-188K
Financing cash flow
Cash flow from continuing financing activities
100.39%231.94M
-101.79%-481K
166.15%232.02M
-60.57%115.74M
7,595.25%26.83M
-70.14%87.18M
225.47%2.08M
-128.31%-351K
27.56%293.51M
-103.03%-358K
Net common stock issuance
--232.88M
---491K
----
--0
--0
----
----
--0
-69.89%960K
--0
Net preferred stock issuance
--0
--0
----
-61.46%112.22M
39,738.10%24.97M
----
----
----
70.27%291.18M
-100.53%-63K
Proceeds from stock option exercised by employees
-33.13%2.86M
-49.85%830K
949.31%1.51M
70.23%4.27M
95.63%1.66M
-80.62%144K
260.63%2.31M
-41.43%164K
--2.51M
--846K
Net other financing activities
-411.29%-3.8M
-498.06%-820K
-1,262.86%-2.86M
34.79%-744K
--206K
---210K
---225K
---515K
---1.14M
----
Cash from discontinued financing activities
Financing cash flow
100.39%231.94M
-101.79%-481K
166.15%232.02M
-60.57%115.74M
7,595.25%26.83M
-70.14%87.18M
225.47%2.08M
-128.31%-351K
27.56%293.51M
-103.03%-358K
Net cash flow
Beginning cash position
-40.83%242.21M
62.94%413.5M
16.95%205.43M
113.10%409.37M
-42.23%253.77M
6.40%175.66M
63.50%291.23M
113.10%409.37M
--192.1M
122.84%439.27M
Current changes in cash
179.59%133.05M
-230.76%-38.25M
166.39%208.07M
-176.94%-167.17M
61.33%-11.56M
-71.51%78.11M
-786.52%-115.57M
-745.27%-118.14M
13.10%217.27M
-495.46%-29.9M
End cash Position
54.93%375.25M
54.93%375.25M
62.94%413.5M
-40.83%242.21M
-40.83%242.21M
-42.23%253.77M
6.40%175.66M
63.50%291.23M
113.10%409.37M
113.10%409.37M
Free cash flow
-41.58%-163.4M
-69.42%-51.49M
-84.64%-47.81M
-51.38%-115.41M
-2.87%-30.39M
-48.19%-25.89M
-95.26%-26.76M
-108.56%-32.36M
-171.69%-76.24M
-65.84%-29.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
Unqualified Opinion
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -42.11%-163.28M-69.41%-51.44M-85.43%-47.77M-52.34%-114.9M-3.45%-30.37M-49.30%-25.76M-95.92%-26.58M-111.14%-32.19M-181.84%-75.42M-77.76%-29.35M
Net income from continuing operations -80.23%-235.93M-286.31%-108.73M-80.71%-53.03M44.84%-130.9M-4.36%-28.15M83.52%-29.34M-78.54%-30.37M-181.25%-43.04M-139.05%-237.31M-34.86%-26.97M
Operating gains losses -------------988.68%-577K---316K---16K32.32%-134K5.93%-111K59.23%-53K----
Depreciation and amortization 12.46%668K12.93%166K18.49%173K10.41%594K12.21%147K-2.67%146K23.20%154K11.36%147K412.38%538K107.94%131K
Other non cash items 338.98%67.38M8,017.15%64.86M-16.44%859K-90.29%15.35M-0.50%799K-99.34%1.03M11.44%302K8,162.50%13.22M123.38%158.09M-82.72%803K
Change In working capital -28.08%-8.9M-153.27%-13.11M-314.95%-1.19M-623.00%-6.95M-15.56%-5.18M-75.38%555K-20.97%1.73M-338.96%-4.06M69.24%-961K-97.44%-4.48M
-Change in prepaid assets -214.25%-11.4M-293.18%-8.13M-642.46%-6.89M-60.53%-3.63M8.98%-2.07M-37.08%-928K-24.02%136K-251.08%-769K-448.54%-2.26M-2,451.69%-2.27M
-Change in payables and accrued expense 305.96%5.91M-203.85%-4.07M207.69%6.57M-149.41%-2.87M133.39%3.92M-32.43%2.13M-21.11%1.79M-718.64%-10.72M355.64%5.8M186.33%1.68M
-Change in other current assets --0--0--0137.48%1.37M-72.46%-6.25M-1,080.00%-49K--051,046.67%7.67M-3,004.24%-3.66M-10,758.82%-3.62M
-Change in other current liabilities -86.36%-3.4M-16.90%-913K-44.35%-869K-117.12%-1.83M-194.72%-781K-159.48%-602K2.44%-200K-74.82%-243K-159.57%-841K1.12%-265K
Cash from discontinued investing activities
Operating cash flow -42.11%-163.28M-69.41%-51.44M-85.43%-47.77M-52.34%-114.9M-3.45%-30.37M-49.30%-25.76M-95.92%-26.58M-111.14%-32.19M-181.84%-75.42M-77.76%-29.35M
Investing cash flow
Cash flow from continuing investing activities 138.32%64.39M270.32%13.68M42.66%23.82M-20,464.63%-168.01M-4,171.28%-8.03M3,151.74%16.69M-83,450.46%-91.07M-317,159.26%-85.61M92.73%-817K39.35%-188K
Net PPE purchase and sale 77.10%-117K-91.30%-44K71.54%-37K37.45%-511K87.77%-23K76.23%-130K-66.97%-182K-751.85%-176K37.15%-817K85.54%-188K
Net investment purchase and sale 144.72%69.09M328.69%18.31M41.78%23.85M---154.5M---8.01M--16.82M---90.89M---72.43M--0----
Net other investing changes 64.69%-4.59M-----------13M--0--0--0---13M--------
Cash from discontinued investing activities
Investing cash flow 138.32%64.39M270.32%13.68M42.66%23.82M-20,464.63%-168.01M-4,171.28%-8.03M3,151.74%16.69M-83,450.46%-91.07M-317,159.26%-85.61M92.73%-817K39.35%-188K
Financing cash flow
Cash flow from continuing financing activities 100.39%231.94M-101.79%-481K166.15%232.02M-60.57%115.74M7,595.25%26.83M-70.14%87.18M225.47%2.08M-128.31%-351K27.56%293.51M-103.03%-358K
Net common stock issuance --232.88M---491K------0--0----------0-69.89%960K--0
Net preferred stock issuance --0--0-----61.46%112.22M39,738.10%24.97M------------70.27%291.18M-100.53%-63K
Proceeds from stock option exercised by employees -33.13%2.86M-49.85%830K949.31%1.51M70.23%4.27M95.63%1.66M-80.62%144K260.63%2.31M-41.43%164K--2.51M--846K
Net other financing activities -411.29%-3.8M-498.06%-820K-1,262.86%-2.86M34.79%-744K--206K---210K---225K---515K---1.14M----
Cash from discontinued financing activities
Financing cash flow 100.39%231.94M-101.79%-481K166.15%232.02M-60.57%115.74M7,595.25%26.83M-70.14%87.18M225.47%2.08M-128.31%-351K27.56%293.51M-103.03%-358K
Net cash flow
Beginning cash position -40.83%242.21M62.94%413.5M16.95%205.43M113.10%409.37M-42.23%253.77M6.40%175.66M63.50%291.23M113.10%409.37M--192.1M122.84%439.27M
Current changes in cash 179.59%133.05M-230.76%-38.25M166.39%208.07M-176.94%-167.17M61.33%-11.56M-71.51%78.11M-786.52%-115.57M-745.27%-118.14M13.10%217.27M-495.46%-29.9M
End cash Position 54.93%375.25M54.93%375.25M62.94%413.5M-40.83%242.21M-40.83%242.21M-42.23%253.77M6.40%175.66M63.50%291.23M113.10%409.37M113.10%409.37M
Free cash flow -41.58%-163.4M-69.42%-51.49M-84.64%-47.81M-51.38%-115.41M-2.87%-30.39M-48.19%-25.89M-95.26%-26.76M-108.56%-32.36M-171.69%-76.24M-65.84%-29.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion----Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg